Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

MFDSRegulator guidanceLot release and sample testingBiologicsHigh confidenceLast verified October 13, 2026

MFDS national lot release regulation

Regulation on Designation, Approval Procedure and Method of National Lot Release Drugs

Current edition

MFDS Notice 2025-77 of November 28, 2025, in force November 29, 2025

About this standard

Sets which drugs need national lot release, the application, the review of documents, the testing and the approval procedure.

Recognition by market

Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts

No market listing is published yet.

Testing requirements that cite it

Open the market page and its pathway pages for the full requirement, protocol and report content

Related standards: MHRA Responsible Person (import) guidance, EudraLex Volume 4 Annex 16, HC Lot Release Program guidance, TGA vaccine batch release, MFDS imported drug management regulation, RDC 669/2022, RDC 670/2022, RDC 900/2024, RDC 944/2024, SFDA lot release policy, Taiwan biological product lot release regulations. See all standards.

Not legal or regulatory advice. Check the current official rules before you act. Parts of the approvals data are official open data reused under open licences. Data sources.

LinkedInLinkedInXXYouTubeYouTube